市場調査レポート
商品コード
1499971
シングルユースアセンブリの世界市場の評価:製品別、ソリューション別、用途別、最終用途別、地域別、機会、予測(2017年~2031年)Single-Use Assemblies Market Assessment, By Product, By Solution, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
シングルユースアセンブリの世界市場の評価:製品別、ソリューション別、用途別、最終用途別、地域別、機会、予測(2017年~2031年) |
出版日: 2024年06月25日
発行: Market Xcel - Markets and Data
ページ情報: 英文 231 Pages
納期: 3~5営業日
|
世界のシングルユースアセンブリの市場規模は、2023年の36億9,000万米ドルから2031年に127億2,000万米ドルに達すると予測され、2024年~2031年の予測期間にCAGRで16.73%の成長が見込まれます。市場の成長は、製薬・バイオ医薬品部門の急成長、生物製剤への投資の増加、新しい製品や技術の導入、医薬品開発プロセスを迅速化する活動の高まり、感染症の流行によって促進されています。
企業による医薬品を迅速に市場に投入する活動の高まりは、世界のシングルユースアセンブリ市場の大きな動向の1つです。2024年4月、SaniSure Limitedは、医薬品充填プロセスの再現性、安全性、効率性を高めるカスタムシングルユース充填アセンブリ、Fill4Sureを発売しました。高性能チューブ、シリコンオーバーモールディング、低微粒子2Dサージバッグ、接着剤・オイルフリーOEM、カスタム設計針などの機能により、汚染リスクを最小化し製品の純度を確保します。これらの先進機能はまた、バイオプロセスやバイオマニュファクチャリングプロセスを合理化し、メーカーがサプライチェーンを守り、生産能力を拡大するのに役立ちます。このようなコスト効率に優れたオーダーメイドの効率性は、産業の進化する要件に対応するための無理のないスケールアップを支援します。
生物製剤への投資の増加も、市場の成長を後押しすると予測されます。2024年1月、AbbVieはシンガポールの生物製剤製造施設を拡張するために2億2,300万米ドルを投資すると発表しました。この拡張は2026年に完了し、2万4,000リットルの生物製剤生産能力と100人の新規雇用が追加される予定です。この投資は、同社の製造ネットワークの世界の拡大を支援し、がんと免疫学のパイプラインをサポートすることが期待されています。さらに、シングルユースアセンブリは、プロセス中間貯蔵、培地・緩衝液調製、下流処理、上流処理など、生物製剤製造部門のさまざまな段階で使用されています。
研究開発活動の活発化が市場需要を押し上げる
世界中のさまざまな地域で感染症や慢性疾患の患者が増加していることから、シングルユースアセンブリを必要とするワクチンの需要が高まっています。このため、感染症に伴う有害な影響を軽減し、天然痘のような深刻なウイルスや病原体を根絶し、子供の死亡率を低下させるワクチン生産への投資が増加しています。National Institute of Health(NIH)などの各種政府機関、慈善財団、Bill and Melinda Gates Foundationや欧州委員会などの超国家機関も、ワクチンの研究開発活動に資金を提供しています。世界保健機関(WHO)の推計によると、2021年に1,410億米ドル、約160億回分のワクチンが供給されます。シングルユースアセンブリは、洗浄やダウンタイムの削減によるコスト効率を実現し、汚染による製品ロスのリスクを最小限に抑えることから、こうした要因が需要を押し上げています。
新製品の上市が市場成長を支える
ワークフローの合理化を支援し、迅速な導入を可能にする新製品を開発する活動の活発化は、世界のシングルユースアセンブリ市場の主な成長促進要因の1つです。2022年3月、Dover Corporationは無菌液体を取り扱うための液体用シングルユースバイオプロセシングバッグを発売しました。同社はまた、粉末(プレフィルド、非プレフィルド)と無菌液体製品の提供も拡大しています。同社の供給面での評判、世界的なフットプリント、品質は、顧客の進化する要求にスケールとスピードで応えられることを保証しています。
こうした発展により、顧客独自の要件に合わせた包括的ソリューションの提供が可能になるため、世界のシングルユースアセンブリ市場の需要拡大が見込まれます。また、これらによって先進技術を利用した製品やすぐに導入可能で手頃な価格の革新的なソリューションを利用できるようになるため、市場の成長にもプラスの影響を与えます。
当レポートでは、世界のシングルユースアセンブリ市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。
Global single-use assemblies market is projected to witness a CAGR of 16.73% during the forecast period 2024-2031F, growing from USD 3.69 billion in 2023 to USD 12.72 billion in 2031F. The market's growth is augmented by the rapid growth of the pharmaceutical and biopharmaceutical sectors, increasing investments towards biologics, the introduction of novel products and technologies, growing efforts to expedite the drug development process, and the increasing prevalence of infectious diseases.
Rising efforts by companies to expedite drugs to market are among the major global single-use assembly market trends. In April 2024, SaniSure Limited launched Fill4Sure, a custom single-use filling assembly to increase drug product filling processes' repeatability, safety, and efficiency. Features such as high-performance tubing, silicone over-molding, low-particulate 2D surge bags, adhesive and oil-free OEM, and custom-designed needles ensure product purity by minimizing contamination risks. These advanced features also streamline bioprocessing and biomanufacturing processes, aiding the manufacturer in securing supply chains and expanding their capacity. Such cost-efficient and tailor-made efficiencies aid in effortless scaling up to meet the industry's evolving requirements.
Increasing investments in biologics are also expected to aid the market's growth. In January 2024, AbbVie Inc. announced an investment of USD 223 million to expand their Singapore biologics manufacturing facility. The expansion is expected to conclude in 2026 and add 24,000 liters of biologics drug-substance capacity and 100 new jobs. This investment is expected to aid the expansion of the company's manufacturing network globally and support its oncology and immunology pipeline. Additionally, single-use assemblies are used in various stages in the biologics manufacturing sector, including process-intermediate storage, media and buffer preparation, downstream processing, and upstream processing.
Increasing Research and Development Activities Boost Market Demand
The rise in infectious and chronic disease cases in various regions across the globe is propelling the requirement for vaccines, which require single-use assemblies. Due to this, the investments in the production of vaccines are increasing as they aid in reducing the detrimental effects associated with infectious diseases, eradicate major viruses and pathogens, such as smallpox, and decrease child mortality rates. Various government agencies such as the National Institute of Health (NIH), philanthropic foundations and supranational bodies, including the Bill and Melinda Gates Foundation and the European Commission, are also financing vaccine research and development activities. According to estimates from the World Health Organization (WHO), vaccines worth USD 141 billion, approximately 16 billion doses, were supplied in 2021. These factors boost the demand for single-use assemblies as they offer cost efficiency due to reduced cleaning and downtime and minimize the risk of product loss due to contamination.
New Product Launches Support Market Growth
Rising efforts to develop novel products that aid in streamlining workflow while allowing for rapid implementation are one of the major factors bolstering the global single-use assemblies market growth. In March 2022, Dover Corporation launched its liquid single-use bioprocessing bags for handling sterile liquids. The company is also expanding its powder (pre-filled and non-pre-filled) and sterile liquid offerings. Their supply reputation, global footprint, and quality ensure that they can meet the customers' evolving requirements at scale and speed.
Such developments are expected to propel the global single-use assemblies market demand as they allow companies to provide comprehensive solutions tailored to the customer's unique requirements. They also allow for the availability of technologically advanced products and ready-to-implement, affordable, and innovative solutions, thus positively influencing the market's growth.
North America Accounts for Significant Market Share
The market growth in North America is supported by the expansion of the pharmaceutical sector, increasing prevalence of infectious and chronic diseases, and rising emphasis on drug discovery research. Single-use assemblies find applications in patient delivery systems, cell cultivation, lab and drug discovery, and downstream and upstream bioprocessing.
The increasing awareness about the various advantages associated with using single-use assemblies as opposed to their counterparts is also supporting the expansion of the market in North America. Traditionally, process equipment is made of stainless steel, among other metals, and has high maintenance and upfront costs.
The rapid growth of the biotechnology industry in the United States is also expected to offer lucrative growth opportunities to the market as single-use assemblies find applications in various biotechnology domains, such as cell and gene therapy. According to estimates from the Council of State Bioscience Associations (CSBA) and Biotechnology Innovation Organization (BIO), the bioscience industry in the United States was valued at USD 2.9 trillion in 2021.
Pharmaceutical and Biopharmaceutical Companies Hold Significant Market Share
The rapid expansion of the pharmaceutical and biopharmaceutical sectors, owing to the increasing prevalence of various chronic and infectious diseases, supports the segment's growth. The increasing investments by major companies in developing new facilities to combat this growing threat bolstered the market's demand. Single-use assemblies reduce the risk of cross-batch and cross-product contamination and provide a smaller manufacturing footprint. Various sterile sectors, including pharmaceutical and biopharmaceutical sectors, have shifted to single-use assemblies and technologies at some time for a few applications, if not all, over the past few years as they aid in improving facility adaptability and flexibility and increase product integrity.
In February 2024, Thermo Fisher Scientific Inc. announced the opening of its new sterile drug facility in Singapore to ensure the delivery of new vaccines and medicines to the Asia Pacific market. The facility has been established with assistance from the Singapore Economic Development Board (EDB) and is in alignment with the efforts of the government to prepare for health emergencies that can emerge in the future. The increasing development of such facilities is expected to propel the requirement for single-use assemblies in the coming years, owing to their various advantages.
Future Market Scenario (2024-2031F)
According to the global single-use assemblies market analysis, the expansion of the pharmaceutical sector, coupled with increasing investments in research and development activities, is expected to bolster the market's demand in the coming years. Features such as reduced environmental impact, faster turnaround and changeover times, high flexibility, and reduced risk of product loss and cross-contamination are expected to propel the utilization of single-use assemblies in the coming years. Continuous efforts of key market players to enhance leak resistance and strength of single-use assemblies are also expected to provide lucrative growth opportunities to the market.
Key Players Landscape and Outlook
New launches by the key market players are bolstering the global single-use assemblies market size. In April 2023, Merck & Co., Inc. launched Ultimus films to provide leak resistance and superior strength in single-use assemblies used in bioprocessing liquid applications. The film is designed using a proprietary woven nylon structure to provide protection against fatigue, tears, leaks, and abrasion, as well as improved resilience and durability and enhanced bag strength. Incorporating woven nylon also provides ease of handling, conformity, and flexibility, which are essential for single-use processing. Such developments are expected to offer lucrative growth opportunities to the market in the coming years as they provide durable and stronger solutions to end-users while minimizing disruptions and increasing operational efficiency.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work